Understanding how a key protein interacts with eye lens membranes in cataract development
Interaction of alpha-crystallin with cholesterol bilayer domains in cataract formation
This work explores how a protein called alpha-crystallin binds to eye lens membranes, which can lead to cataracts.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boise State University NIH-funded |
| Lab location | 1 site (Boise, United States) |
| Project ID | NIH-11179163 on NIH RePORTER |
What this research studies
Our eyes have a special protein, alpha-crystallin, that helps keep the lens clear by preventing other proteins from clumping together. As we get older and cataracts form, this helpful protein moves from inside the lens cells to the cell membranes. We want to discover exactly how this protein attaches to the lens membrane, especially focusing on the role of cholesterol in this process. By understanding this mechanism, we hope to find new ways to prevent or even reverse cataracts. This project builds on our previous findings to delve deeper into these important interactions.
Who could benefit from this research
Good fit: This foundational research is for anyone interested in the basic biological processes that contribute to age-related cataracts.
Not a fit: Patients seeking immediate treatment or direct clinical intervention will not receive benefit from this basic science project.
Why it matters
Potential benefit: If successful, this work could lead to new strategies for preventing or reversing cataract development by targeting the protein-membrane interaction.
How similar studies have performed: This project builds upon previous successful findings from the same team, which have directed them to more detailed studies.
Where this research is happening
Boise, United States
- Boise State University — Boise, United States (Active)
Researchers
- Principal investigator: Mainali, Laxman — Boise State University
- Study coordinator: Mainali, Laxman
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.